An Open Label, Phase II Trial of Continuous Low-Irradiance Photodynamic Therapy (CLIPT) Using Verteporfin (Visudyne®) for the Treatment of Cutaneous Metastases of Breast Cancer
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT02939274 |
|
Recruitment Status : Unknown
Verified July 2018 by Rogers Sciences Inc..
Recruitment status was: Recruiting
First Posted : October 20, 2016
Last Update Posted : July 20, 2018
|
Sponsor:
Rogers Sciences Inc.
Information provided by (Responsible Party):
Rogers Sciences Inc.
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Unknown |
|---|---|
| Estimated Primary Completion Date : | December 2018 |
| Estimated Study Completion Date : | December 2019 |